• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.14% Nasdaq Down 1.06%

    More On ISIS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    57.56 Down 0.28(0.48%) Dec 21 - Nasdaq Real Time Price
    Prev Close:57.56
    Open:57.56
    Bid:N/A
    Ask:N/A
    1y Target Est:65.11
    Beta:1.89939
    Next Earnings Date:N/A
    Day's Range:56.70 - 58.45
    52wk Range:37.38 - 77.80
    Volume:998,037
    Avg Vol (3m):1,722,070
    Market Cap:6.91B
    P/E (ttm):483.70
    EPS (ttm):0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ISISDown 0.48%6.91B
    ENZDown 0.23%202.70M
    SRPTUp 2.66%524.69M
    GILDDown 0.99%123.61B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback